Career Moves for Life Scientists: Where is the Science Actually Leading You?
The COVID-19 pandemic has created great uncertainty, but also great opportunity, for life scientists. Historically sturdy career paths ha...
Aug 24, 2022 / Read More
Early Commercialization and Financing Challenges with New Materials
MXenes are transition metal carbides that can be synthesized as two-dimensional sheets. The more widely known 2D material, graphene, is b...
Aug 24, 2022 / Read More
A Hot Summer in the Valley of Death
Historically, the chance of success for any new company would approach better-than-even-odds only very near the commercialization finish ...
Aug 08, 2022 / Read More
An Angel Investor’s Primer to SBIR Grants
Early investors from time to time consider backing companies that have previously received these awards. At other times, a company’s futu...
Mar 09, 2022 / Read More
Where New Medical Devices Come From
The conversation started with a look at where NIH SBIR grant funding — one of the earliest types of funding for a new company — flows geo...
Nov 29, 2021 / Read More
Mapping the Medical Device Start-Up Ecosystem
Medical devices are ubiquitous in US healthcare— everything from the delivery room’s sterile gloves and umbilical cord clamps to the brea...
Oct 11, 2021 / Read More
COVID-19 Partnerships: ArgoPond Teams with Doctors Emma Meagher and Ian Frank, University of…
During the COVID-19 pandemic, Argo Pond provided research strategic advising and clinical trial oversight to research teams across the US...
Oct 03, 2021 / Read More
COVID-19 Partnerships: ArgoPond Teams with Katharine Bar, University of Pennsylvania
During the COVID-19 pandemic, ArgoPond provided services to several research teams by leading clinical trial Data and Safety Monitoring B...
Oct 03, 2021 / Read More
COVID-19 Research Notes: ArgoPond Teams with Julio Chirinos and Jordana Cohen, University of…
During the COVID-19 pandemic, ArgoPond provided services to several research teams by leading clinical trial Data and Safety Monitoring B...
Oct 03, 2021 / Read More
America’s Biggest Biotech Angel
With an FY2020 budget of $42 billion, most of their expenditures are university grants supporting either new discoveries or early-state c...
Jul 23, 2021 / Read More